charbonneau
Divide et impera
> “That conclusion is misleading and inaccurate,” Subramanian told me of Horowitz’s Blaze column over email. “This paper supports vaccination as an important strategy for reducing infection and transmission, along with hand-washing, mask-wearing, and physical distancing.”
Attenuated vaccines have been under development for centuries. Do they even need trials?
I prefer their alternative headline “What the latest COVID research says about breakthrough cases and transmission”
Immunologist isn't convinced of risk. Cites not peer reviewed laboratory evidence.
> We note that almost 43% of patients after influenza had at least one long-COVID feature recorded (Table 1) including 29.7% during the 90- to 180-day period. In this regard, we suggest researchers take a broad and balanced view as to the nature and specificity of long-COVID.
> Some key research on the unvaccinated
> It may well be that some of the unvaccinated are a bit like cats stuck in a tree
What a silly bunch, the unvaccinated
Two Arms and a Head (2008)
> If there are no conclusive results proving that out for ersatz cloth masks, then the scientific approach is to try better protective equipment until it does become effective.
I respect your view and completely agree that personal protective equipment should be examined further. The current evidence is definitely sufficient for a strong mask recommendation. I’m only critical of mandates (or bans) in this situation as they push people away from doing their own research and lead to bizarre scenes, as you encountered it with your respirator.
http://web.archive.org/web/20180115194946/https://www.nytime...
> The opposing position to "wear a mask to protect others" should have been "wear a mask to protect yourself and your family"
Should the mask topic also prohibit any divergence? Is the evidence so unambiguous that all raised objections can only be a tragic misleading with disastrous results?
Cochrane review (Nov 2020): "We included nine trials (of which eight were cluster‐RCTs) comparing medical/surgical masks versus no masks to prevent the spread of viral respiratory illness (two trials with healthcare workers and seven in the community). There is low certainty evidence from nine trials (3507 participants) that wearing a mask may make little or no difference to the outcome of influenza‐like illness (ILI) compared to not wearing a mask (risk ratio (RR) 0.99, 95% confidence interval (CI) 0.82 to 1.18)"
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD...
Sure, Bill, very heartbreaking:
> Oxford University surprised and pleased advocates of overhauling the vaccine business in April by promising to donate the rights to its promising coronavirus vaccine to any drugmaker [...] A few weeks later, Oxford—urged on by the Bill & Melinda Gates Foundation—reversed course. It signed an exclusive vaccine deal with AstraZeneca that gave the pharmaceutical giant sole rights and no guarantee of low prices—with the less-publicized potential for Oxford to eventually make millions from the deal and win plenty of prestige.
https://khn.org/news/rather-than-give-away-its-covid-vaccine...
Elon Musk, June 11th 2020
Conspiracy theory: Meteorites aren't real. It's all just debris. Construction companies bribe astronomers so that they won't face criminal charges.
The leading cause of deaths in this age group are accidents [2]. A lot of these accidents are preventable [3].
[1] https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm
[2] https://www.cdc.gov/nchs/fastats/child-health.htm
[3] https://www.nhs.uk/conditions/baby/first-aid-and-safety/safe...
* Since 1/1/2021
On 1/15/2021, 0.12% of the Ohio population were fully vaccinated [1]
> CureVac estimates that the earliest potential approval of [first-generation vaccine] would come in the second quarter of 2022. By this time, the companies expect the candidates from the second-generation vaccine program to have progressed to late-stage clinical development.
What's the goal of having a COVID vaccine market ready in the third/fourth quarter of 2022? And how will they achieve it? Will it be authorized under an Emergency Use Authorization? Do they anticipate that the circumstances justifying EUA's will continue?
[1] https://www.curevac.com/en/2021/10/12/curevac-to-shift-focus...
Reasonable according to whom?
Could you please share a meaningful study that comes to this conclusion and does not ignore all potential confounding factors? (I don't mean it in a confrontational way; I'm genuinely curious since I only managed to find heavily confounded data)
Never!
"I'll only get the darn shot if it receives a Nobel Prize!"
[1] https://www.fiercepharma.com/pharma/merck-ceo-ken-frazier-ge...
[2] Before the trolls arrive: Yes, I know you can get a GTT 165 for $26.9M, but it lacks the Speed Package (2x MTU 16V, 1,790 kW). Might as well buy a rubber boat.